Skip to Main Content

Paper Details

Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial.
Trials
8
2022
Author NameAffiliation
Christopher Kai-Shun LeungThe University of Hong Kong
Christopher Kai-Shun LeungHong Kong Eye Hospital
Christopher Kai-Shun LeungThe Chinese University of Hong Kong
  • 1 - 3

Datasets

Release 1.2